Literature DB >> 12132320

Phylogenetic analysis of the envelope protein (domain III) of dengue 4 viruses.

Javier Mota1, José Ramos-Castañeda, Rebeca Rico-Hesse, Celso Ramos.   

Abstract

OBJECTIVE: To evaluate the genetic variability of domain III of envelope (E) protein and to estimate phylogenetic relationships of dengue 4 (Den-4) viruses isolated in Mexico and from other endemic areas of the world.
MATERIAL AND METHODS: A phylogenetic study of domain III of envelope (E) protein of Den-4 viruses was conducted in 1998 using virus strains from Mexico and other parts of the world, isolated in different years. Specific primers were used to amplify by RT-PCR the domain III and to obtain nucleotide sequence. Based on nucleotide and deduced aminoacid sequence, genetic variability was estimated and a phylogenetic tree was generated. To make an easy genetic analysis of domain III region, a Restriction Fragment Length Polymorphism (RFLP) assay was performed, using six restriction enzymes.
RESULTS: Study results demonstrate that nucleotide and aminoacid sequence analysis of domain III are similar to those reported from the complete E protein gene. Based on the RFLP analysis of domain III using the restriction enzymes NIa III, Dde I and Cfo I, Den-4 viruses included in this study were clustered into genotypes 1 and 2 previously reported.
CONCLUSIONS: Study results suggest that domain III may be used as a genetic marker for phylogenetic and molecular epidemiology studies of dengue viruses. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132320      PMCID: PMC3085193          DOI: 10.1590/s0036-36342002000300006

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  25 in total

1.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature.

Authors:  R Rico-Hesse
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

2.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

3.  Phylogenetic relationships of dengue-2 viruses.

Authors:  J A Lewis; G J Chang; R S Lanciotti; R M Kinney; L W Mayer; D W Trent
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

4.  Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia.

Authors:  E Chungue; V Deubel; O Cassar; M Laille; P M Martin
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

5.  Molecular evolution and epidemiology of dengue-3 viruses.

Authors:  R S Lanciotti; J G Lewis; D J Gubler; D W Trent
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

6.  Epidemic dengue 4 in the Yucatán, México, 1984.

Authors:  M A Loroño Pino; J A Farfán Ale; E P Rosado Paredes; G Kuno; D J Gubler
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1993 Sep-Oct       Impact factor: 1.846

7.  Molecular epidemiology of type 1 polioviruses isolated in Israel and defined by restriction fragment length polymorphism assay.

Authors:  A Vonsover; R Handsher; M Neuman; S Guillot; J Balanant; H Rudich; E Mendelson; T Swartz; R Crainic
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

8.  A PCR-restriction enzyme technique for determining dengue virus subgroups within serotypes.

Authors:  V Vorndam; G Kuno; N Rosado
Journal:  J Virol Methods       Date:  1994-07       Impact factor: 2.014

9.  Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses.

Authors:  D J Gubler; G Kuno; G E Sather; M Velez; A Oliver
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

Review 10.  Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas.

Authors:  D J Gubler; D W Trent
Journal:  Infect Agents Dis       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.